Micronoma in the News
Special Report: Life Science, Merging the Biological With the Computational
When scientists began mapping of the human genome, the discoveries in our DNA unleashed an era of biology that advanced breakthroughs in diagnostics and biomedicine beyond what was imaginable when the work began. Today, with DNA sequencers readily available in many...
Microbiome Therapeutics Try a Lighter Touch
The revelation that our commensal bacteria play important roles in health and disease has turned the microbiome into one of the most active frontiers of biomedicine. Yet our efforts to turn our “inner bugs” into drugs have long been limited to investigational fecal...
Could Cancer’s Microbiome Help Diagnose and Treat the Disease?
As a postdoc at the Broad Institute of MIT and Harvard in 2008, cancer biologist Ravid Straussman worked on a collaborative effort to screen normal cells for their influence on cancer cells’ responses to various anticancer therapies. The project turned up hundreds of...
Female Tech Leaders
Interview with Sandrine Miller-Montgomery, Micronoma, Inc. What are your suggestions to encourage more young women to pursue careers in tech? There are so many facets to working in tech that it is worth considering regardless of being scientific minded or not...the...
Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant
NEW YORK – Microbial cancer detection firm Micronoma said Tuesday that it is collaborating with... Read Article
Human Blood Harbors Cell-Free Microbial DNA
After controlling for high levels of bacterial contamination in their lab and reagents, researchers detect microbial genetic material in plasma samples from healthy people and cancer patients. Read the full article in The Scientist
Micronoma Closes $3.5M Convertible Debt Financing Round
Micronoma, a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, closed a $3.5m convertible debt financing round. Read full story.
Microbiome-based diagnostics and biomarkers
Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine. Read how Micronoma fits in this emerging landscape. Read Article
Micronoma Establishes Scientific Advisory Board
Read the article at CIO Applications
People in the News: New Appointments at Thrive Earlier Detection, Micronoma, Theralink Technologies
Read the full article on GenomeWeb.
Micronoma Appoints Magda Marquet to Chairman of the Board
San Diego-based Micronoma, a startup using microbiome analysis for early cancer detection, has appointed Magda Marquet as chairman of the firm’s board.
Prime Time for the Microbiome
Microbiomics is taking a sharp turn. Until now, the field was limited to fecal transplants from healthy patients to those with gut conditions. The transplant is an awkward procedure that also creates regulatory and other challenges. Read More.
S.D. biotech lab with ties to UC San Diego works to develop faster cancer detection
A San Diego-based biotech firm that has co-founders from UC San Diego is working to develop and commercialize a minimally invasive method for early cancer detection and recently closed a $3 million seed financing round to further its results. Read full story at La...
Micronoma Launches with $3 Million Seed Funding
Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based method, announced today that it has closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC. Read More.
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More
San Diego-based Micronoma closed $3 million in seed financing to support the development of its microbiome-based cancer detection technology. Full Article
Start-Up Developing Microbial Cancer Detection Tests
13 Aug. 2020. A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples. Micronoma, in San Diego, is also raising $3 million in its seed funding round, equity...
Micronoma Finds $3M For Early Cancer Detection
San Diego-based Micronoma, a startup working on early cancer detection, announced this morning that it has raised $3M in a seed financing round. The funding was led by SymBiosis, LLc. According to the company, Read Article
Microbial Signatures in Blood Are Associated with Various Cancers
A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types. Read More.
Microbiome analyses of blood and tissues suggest cancer diagnostic approach
The story behind this paper begins with the loss of my grandmother to pancreatic cancer and the relentless pursuit to understand her disease. Projects along my educational path seemed like diversions (e.g. infectious disease genomics) but provided valuable skills to...
Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer
From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages When Gregory Poore was a freshman in college, his otherwise healthy grandmother was shocked to learn that she had late-stage pancreatic cancer. The condition was...

Website Terms of Use, Privacy Policy, and Licenses
Micronoma, INC., CLIA #05D2253538
Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.
Contact Us
If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.
Micronoma
6342 Ferris Square
San Diego, CA 92121